International Oncology Conference 2025: Pakistan’s Rising Role in Global Cancer Care

In 2025, Pakistan hosted a series of landmark oncology meetings that brought together global experts, local oncologists, researchers, and pharmaceutical leaders. These conferences showcased Pakistan’s growing commitment to advancing cancer care and to bridging the gap between international innovation and local patient needs.

🏛 Key Events in 2025

1. Shaukat Khanum Cancer Symposium (Lahore, October 24–26, 2025)

• Largest oncology gathering in Pakistan, with around 5,920 delegates.
• Featured 111 expert speakers, including 44 international voices from 15 countries.
• Sessions covered breast cancer, nuclear medicine, surgical oncology, and multidisciplinary care pathways.
• The Ahsan Rashid Memorial Award session highlighted Pakistan’s research excellence, with work judged by global oncology leaders.

2. International Conference on Oncology (ICO, Karachi, December 29–30, 2025)

• Organized under the banner of the World Academy of Science, Engineering and Technology (WASET).
• Covered diverse oncology fields including radiation therapy, head and neck surgery, blood and marrow transplantation, gastrointestinal cancers, and breast oncology.
• Provided a platform for academic paper submissions, oral and poster presentations, and international networking.

3. ONCO 2025 – 26th Annual Cancer Congress (Multan, 2025)

• Organized by the Pakistan Society of Clinical Oncology (PSCO).
• Focused on clinical oncology, radiation oncology, hematology, and nuclear medicine.
• Reinforced PSCO’s role as the largest national body representing cancer specialists and shaping oncology practice standards in Pakistan.

🔬 Scientific and Strategic Highlights

• Immunotherapy and precision medicine: Across meetings, sessions emphasized biomarkers, genetic profiling, and targeted therapies as core tools for modern cancer care.
• Multidisciplinary collaboration: Surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists worked together to refine tumor boards and shared decision-making models.
• Global–local integration: International speakers linked Pakistan’s oncology community to global research networks, guidelines, and trial opportunities.
• Pharma engagement: Companies showcased oncology pipelines, discussed affordability strategies, and explored options for local manufacturing and technology transfer.

✨ Strategic Takeaway

Taken together, these conferences were more than a series of scientific meetings—they were a clear statement of intent. Pakistan is positioning itself as a regional hub for oncology dialogue, blending global collaboration with local innovation and system-building.

For pharmaceutical and biotech companies, 2025’s oncology calendar in Pakistan offered:

• Platforms to showcase research and development pipelines in solid tumors and hematologic malignancies.
• Opportunities to engage with media, policymakers, and clinicians on access, reimbursement, and innovation.
• Visibility in shaping the narrative around Pakistan’s oncology future and its integration into global cancer-care strategies.

Closing Note

As Pakistan prepares for ELCC 2026 in Copenhagen, the International Oncology Conference 2025—taken in the broad sense of this landmark year of events—stands as proof that the country is ready to contribute meaningfully to global cancer care. By aligning local innovation with international collaboration, Pakistan’s oncology community is carving out a distinct and influential space on the world stage.